Court rejects Novo bid to block Lilly obesity drug ads

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 27 Oct, 16:03 UTC

Novo failed to prove that Lilly’s campaign — which featured claims of obesity drug superiority — meaningfully harmed the Danish company’s sales, a federal judge ruled.

policyscience

Sources

• T2Court rejects Novo bid to block Lilly obesity drug adsBioPharma Dive / Healthcare Dive / MedTech Dive27 Oct, 16:03